search
Back to results

Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health (NiPPeR)

Primary Purpose

Hyperglycemia

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Study nutritional drink
Standard nutritional drink
Sponsored by
University of Southampton
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Hyperglycemia focused on measuring Nutrition, Glucose metabolism, Body composition

Eligibility Criteria

18 Years - 38 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Women aged 18-38 years
  • Planning to conceive within 6 months
  • Able to provide written, informed consent
  • In Singapore: Chinese, Malay and Indian ethnicity or mixed Chinese/Malay/Indian ethnicity

Exclusion Criteria:

  • Pregnant or lactating at recruitment
  • Assisted fertility, apart from those taking clomiphene or letrozole alone
  • Pre-existing diabetes (type 1 or type 2)
  • Oral or implanted contraception currently or in the last month, or with an Intrauterine Contraceptive Device (IUCD) in situ
  • On metformin or systemic steroids currently or in the last month
  • Known serious food allergy
  • Not able to give informed consent
  • Women on anticonvulsants (who are treated with high dose B vitamins in pregnancy) currently or in the last month
  • On treatment for Human Immunodeficiency Virus (HIV), Hepatitis B or C currently or in the last month

The partners of the women (over 16 years of age) will also be invited to participate in the study. After having gained written informed consent, fathers will have blood, urine, hair sampling, cheek swabs and body measurements taken and will complete a health and a lifestyle questionnaire at one of the visits during pregnancy.

The mother will consent for their babies to have body measurements, buccal, hair, stool samples and allergy testing from birth to 3.5 years.

Sites / Locations

  • The University of Auckland
  • National University Hospital
  • University Hospital Southampton NHS Foundation Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention (study nutritional drink)

Control (standard nutritional drink)

Arm Description

Study nutritional drink comes in the form of a sachet to mix with water & take twice a day (once in the morning and once in the evening). The drink will be taken before the participant becomes pregnant (for up to 1 year) and throughout pregnancy.

Standard nutritional drink comes in the form of a sachet to mix with water & take twice a day (once in the morning and once in the evening). The drink will be taken before the participant becomes pregnant (for up to 1 year) and throughout pregnancy.

Outcomes

Primary Outcome Measures

Glucose tolerance during pregnancy

Secondary Outcome Measures

Duration of gestation
Pregnancy weight gain and body composition
Postpartum weight retention and body composition
Change in body composition before, during and after gestation
Clinical pregnancy, pregnancy loss and live birth rates, including median time to conception of those who conceive during the treatment period and proportions conceiving within 3 months, 6 months and a year of commencing the NiPPeR drink
Gestational diabetes frequency
Hypertensive disorders of pregnancy (pregnancy-induced hypertension and pre-eclampsia/eclampsia)
Nausea and vomiting frequency
Other antenatal, perinatal and postnatal complications
Preconception and antenatal maternal wellbeing/mood (Edinburgh Post-natal Depression Scale and State-Trait Anxiety Inventory)
Postnatal maternal wellbeing/mood (Edinburgh Post-natal Depression Scale and State-Trait Anxiety Inventory)
Mode of labour onset and delivery
Neonatal complications and admission to neonatal care facilities
Preconception maternal micronutrient status (blood analysis)
Antenatal maternal micronutrient status (blood analysis)
Preconception maternal gut microbiota composition and activity profile (analysis of sequencing and transcription data)
Antenatal and postnatal maternal gut and epithelial microbiota composition profile (analysis of sequencing data)
Maternal preconception biochemical, metabolic and molecular profiles
Maternal antenatal biochemical, metabolic and molecular profiles
Placental and cord tissue, and their cellular derivatives: biochemical, metabolic and molecular profiles
Maternal postnatal biochemical, metabolic and molecular profiles
Maternal preconception epigenetic profile
Maternal antenatal epigenetic profile
Maternal postnatal epigenetic profile
Breast milk macronutrient profile (subsample)
Breast milk micronutrient profile (subsample)
Breast milk immune factor profile (subsample)
Breast milk epigenetic profile (subsample)
Breast milk biochemical, metabolic, microbiome and molecular profiles (subsample)
Healthy lactogenesis
Maternal and infant transcriptomics (including of breastmilk)
Intrauterine growth and wellbeing as assessed by antenatal serial ultrasound scans
Offspring birthweight and size at birth
Offspring size for gestational age at birth, less than the 10th, 10th - 90th, and above the 90th percentiles for gestational age
Offspring size for gestational age and sex at birth (percentile and standard deviation scores)
Offspring adiposity (skinfold thicknesses, regional, total and percentage fat mass)
Adiposity gain, body composition and linear growth during infancy and childhood
Cord blood C-peptide
Offspring cardiometabolic profile
Offspring allergic wellbeing
Offspring biochemical, metabolic and molecular profiles
Offspring epigenetic profile
Infant gut microbiota composition and activity
Influence of parental and offspring genotype, sociodemography, body composition, metabolism, lifestyle and diet on the above primary and secondary outcomes at baseline and with the intervention

Full Information

First Posted
July 16, 2015
Last Updated
May 12, 2023
Sponsor
University of Southampton
Collaborators
National University Hospital, Singapore, Auckland UniServices Ltd., Singapore Institute for Clinical Sciences, National University of Singapore, Nestec Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT02509988
Brief Title
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health
Acronym
NiPPeR
Official Title
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health "(NiPPeR)"
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
July 2015 (Actual)
Primary Completion Date
October 2018 (Actual)
Study Completion Date
June 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Southampton
Collaborators
National University Hospital, Singapore, Auckland UniServices Ltd., Singapore Institute for Clinical Sciences, National University of Singapore, Nestec Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study aims to assess whether a nutritional drink taken before conception and continuing through pregnancy, assists in the maintenance of healthy glucose metabolism in the mother and promotes offspring health.
Detailed Description
It is known that maternal insulin resistance and high blood glucose levels in early pregnancy alter the functioning of the placenta in ways that persistently affect the supply of nutrients and fat in the unborn baby. There is an increasing focus on the need to optimise preconception nutrition but as yet, limited preconception interventions that are recognized as promoting health for the mother and her child. The Investigators will recruit up to 1800 women, aged 18-38 years, who are planning a pregnancy in the United Kingdom, Singapore and New Zealand with the aim of securing 600 or more pregnancies. The participants will be randomly allocated to receive the standard nutritional drink or the study nutritional drink. Women who conceive between one and twelve months after starting the nutritional drink will be followed through pregnancy and studied with their babies for three years after delivery. Various testing will be carried out at relevant time points. Mothers will undergo blood, urine, hair and cheek swab sampling, dual-energy X-ray absorptiometry (DXA) scans along with body measurements and health and lifestyle questionnaires. Infants will undergo hair, cheek swab, urine and stool sampling along with body measurements, measurements of body composition and a DXA scan. Placental, cord and other perinatal tissues/samples will be collected. The data collected will allow identification of the contributions of nutritional and lifestyle factors, social and economic status, ethnicity, genetics and metabolomics and gut microbes to maintaining healthy glucose metabolism in pregnancy, enhancing fertility, mood and reproductive outcomes in the mother, and promoting healthy growth, body composition and wellbeing in the children. The effect of the intervention on the primary outcome will be examined in two special interest groups; i) women who are overweight or obese prior to conception & ii) women with documented evidence of dysglycemia prior to conception.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperglycemia
Keywords
Nutrition, Glucose metabolism, Body composition

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1729 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention (study nutritional drink)
Arm Type
Experimental
Arm Description
Study nutritional drink comes in the form of a sachet to mix with water & take twice a day (once in the morning and once in the evening). The drink will be taken before the participant becomes pregnant (for up to 1 year) and throughout pregnancy.
Arm Title
Control (standard nutritional drink)
Arm Type
Active Comparator
Arm Description
Standard nutritional drink comes in the form of a sachet to mix with water & take twice a day (once in the morning and once in the evening). The drink will be taken before the participant becomes pregnant (for up to 1 year) and throughout pregnancy.
Intervention Type
Dietary Supplement
Intervention Name(s)
Study nutritional drink
Intervention Description
Study nutritional drink containing a mix of micronutrients, probiotics and myo-inositol.
Intervention Type
Dietary Supplement
Intervention Name(s)
Standard nutritional drink
Intervention Description
Standard nutritional drink containing a mix of micronutrients.
Primary Outcome Measure Information:
Title
Glucose tolerance during pregnancy
Time Frame
Pregnancy Oral Glucose Tolerance Test (OGTT) measurement at 24 - 32 weeks gestation
Secondary Outcome Measure Information:
Title
Duration of gestation
Time Frame
Up to 43 weeks, derived from estimated date of conception from menstrual and ultrasound scan data and date of delivery
Title
Pregnancy weight gain and body composition
Time Frame
Up to 36 weeks, between date of first pregnancy visit and late gestation
Title
Postpartum weight retention and body composition
Time Frame
Up to 2 years, between date of delivery and 6,12 and 24 months postpartum
Title
Change in body composition before, during and after gestation
Time Frame
Up to 4 years, between preconception, pregnancy and 2 years postpartum
Title
Clinical pregnancy, pregnancy loss and live birth rates, including median time to conception of those who conceive during the treatment period and proportions conceiving within 3 months, 6 months and a year of commencing the NiPPeR drink
Time Frame
Between recruitment and delivery
Title
Gestational diabetes frequency
Time Frame
Pregnancy OGTT measurement at 24 - 32 weeks gestation
Title
Hypertensive disorders of pregnancy (pregnancy-induced hypertension and pre-eclampsia/eclampsia)
Time Frame
Up to 49 weeks, between conception derived from estimated date of conception from menstrual and ultrasound scan data and date of delivery, and up to 6 weeks after delivery
Title
Nausea and vomiting frequency
Time Frame
Up to 36 weeks, between 7 weeks of gestation and delivery
Title
Other antenatal, perinatal and postnatal complications
Time Frame
Up to 49 weeks, between conception from estimated date of conception derived from menstrual and ultrasound scan data, and up to 6 weeks after delivery
Title
Preconception and antenatal maternal wellbeing/mood (Edinburgh Post-natal Depression Scale and State-Trait Anxiety Inventory)
Time Frame
Up to 2 years, between preconception and delivery
Title
Postnatal maternal wellbeing/mood (Edinburgh Post-natal Depression Scale and State-Trait Anxiety Inventory)
Time Frame
Up to 52 weeks, between date of delivery and infant age 1 year
Title
Mode of labour onset and delivery
Time Frame
Delivery
Title
Neonatal complications and admission to neonatal care facilities
Time Frame
Up to 4 weeks post-delivery
Title
Preconception maternal micronutrient status (blood analysis)
Time Frame
Date of second preconception visit up to 1 year before pregnancy
Title
Antenatal maternal micronutrient status (blood analysis)
Time Frame
Up to 30 weeks, between 7 weeks gestation and 37 weeks of gestation
Title
Preconception maternal gut microbiota composition and activity profile (analysis of sequencing and transcription data)
Time Frame
Up to 6 weeks from the start of intervention, date of preconception visit 2 which is up to 1 year before pregnancy
Title
Antenatal and postnatal maternal gut and epithelial microbiota composition profile (analysis of sequencing data)
Time Frame
Up to 18 months, between 7 weeks gestation and post-delivery visits
Title
Maternal preconception biochemical, metabolic and molecular profiles
Time Frame
Up to 6 weeks from the start of intervention, date of second preconception visit which is up to 1 year before pregnancy
Title
Maternal antenatal biochemical, metabolic and molecular profiles
Time Frame
Up to 30 weeks, between 7 weeks gestation and 37 weeks of gestation
Title
Placental and cord tissue, and their cellular derivatives: biochemical, metabolic and molecular profiles
Time Frame
Birth
Title
Maternal postnatal biochemical, metabolic and molecular profiles
Time Frame
6 months after delivery
Title
Maternal preconception epigenetic profile
Time Frame
Preconception to up to 1 year before pregnancy
Title
Maternal antenatal epigenetic profile
Time Frame
Up to 30 weeks, between 7 weeks gestation and 37 weeks of gestation
Title
Maternal postnatal epigenetic profile
Time Frame
6 months after delivery
Title
Breast milk macronutrient profile (subsample)
Time Frame
Up to 1 year, between date of delivery and 1 year postpartum
Title
Breast milk micronutrient profile (subsample)
Time Frame
Up to 1 year, between date of delivery and 1 year postpartum
Title
Breast milk immune factor profile (subsample)
Time Frame
Up to 1 year, between date of delivery and 1 year postpartum
Title
Breast milk epigenetic profile (subsample)
Time Frame
Up to 1 year, between date of delivery and 1 year postpartum
Title
Breast milk biochemical, metabolic, microbiome and molecular profiles (subsample)
Time Frame
Up to 1 year, between date of delivery and 1 year postpartum
Title
Healthy lactogenesis
Time Frame
Up to 1 year, between date of delivery and 1 year postpartum
Title
Maternal and infant transcriptomics (including of breastmilk)
Time Frame
Up to 34 months, between preconception, pregnancy and 1 year postpartum
Title
Intrauterine growth and wellbeing as assessed by antenatal serial ultrasound scans
Time Frame
Up to 30 weeks, between 7 weeks gestation and 37 weeks of gestation
Title
Offspring birthweight and size at birth
Time Frame
At birth
Title
Offspring size for gestational age at birth, less than the 10th, 10th - 90th, and above the 90th percentiles for gestational age
Time Frame
At birth
Title
Offspring size for gestational age and sex at birth (percentile and standard deviation scores)
Time Frame
At birth
Title
Offspring adiposity (skinfold thicknesses, regional, total and percentage fat mass)
Time Frame
Up to 3.5 years, between date of delivery and 3.5 years postpartum
Title
Adiposity gain, body composition and linear growth during infancy and childhood
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Cord blood C-peptide
Time Frame
At delivery
Title
Offspring cardiometabolic profile
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Offspring allergic wellbeing
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Offspring biochemical, metabolic and molecular profiles
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Offspring epigenetic profile
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Infant gut microbiota composition and activity
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Influence of parental and offspring genotype, sociodemography, body composition, metabolism, lifestyle and diet on the above primary and secondary outcomes at baseline and with the intervention
Time Frame
Up to 5.5 years, between preconception, pregnancy and 3.5 years postpartum
Other Pre-specified Outcome Measures:
Title
Health economics analysis (cost benefit analysis)
Time Frame
Composite analysis between preconception visit which is up to 1 year before pregnancy and infant age 3.5 years, assessed up to 5.5 years
Title
Offspring neurocognitive and behavioural development (behavioural and Ages & Stages questionnaires)
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Offspring respiratory development (absence of respiratory symptoms)
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Offspring allergic development (clinical evaluation of atopic disorders and skin prick test reaction diameter)
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Offspring health and wellbeing (questionnaires)
Time Frame
Up to 3.5 years, from birth to infant age 3.5 years
Title
Maternal health and wellbeing
Time Frame
Up to 4 years, between preconception visit which is up to 1 year before pregnancy and up to 2 years after delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
38 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women aged 18-38 years Planning to conceive within 6 months Able to provide written, informed consent In Singapore: Chinese, Malay and Indian ethnicity or mixed Chinese/Malay/Indian ethnicity Exclusion Criteria: Pregnant or lactating at recruitment Assisted fertility, apart from those taking clomiphene or letrozole alone Pre-existing diabetes (type 1 or type 2) Oral or implanted contraception currently or in the last month, or with an Intrauterine Contraceptive Device (IUCD) in situ On metformin or systemic steroids currently or in the last month Known serious food allergy Not able to give informed consent Women on anticonvulsants (who are treated with high dose B vitamins in pregnancy) currently or in the last month On treatment for Human Immunodeficiency Virus (HIV), Hepatitis B or C currently or in the last month The partners of the women (over 16 years of age) will also be invited to participate in the study. After having gained written informed consent, fathers will have blood, urine, hair sampling, cheek swabs and body measurements taken and will complete a health and a lifestyle questionnaire at one of the visits during pregnancy. The mother will consent for their babies to have body measurements, buccal, hair, stool samples and allergy testing from birth to 3.5 years.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wayne Cutfield, BHB MB ChB DCH MD FRACP
Organizational Affiliation
The University of Auckland
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Shiao-Yng Chan, MBBChir (UK), FRCOG (UK), PhD
Organizational Affiliation
National University Hospital, Singapore
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Keith Godfrey, BM PhD FRCP
Organizational Affiliation
MRC Lifecourse Epidemiology Unit, University of Southampton
Official's Role
Principal Investigator
Facility Information:
Facility Name
The University of Auckland
City
Auckland
ZIP/Postal Code
1142
Country
New Zealand
Facility Name
National University Hospital
City
Singapore
ZIP/Postal Code
119074
Country
Singapore
Facility Name
University Hospital Southampton NHS Foundation Trust
City
Southampton
State/Province
Hampshire
ZIP/Postal Code
SO16 6YD
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
28320484
Citation
Godfrey KM, Cutfield W, Chan SY, Baker PN, Chong YS; NiPPeR Study Group. Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial. Trials. 2017 Mar 20;18(1):131. doi: 10.1186/s13063-017-1875-x.
Results Reference
background
PubMed Identifier
33782086
Citation
Godfrey KM, Barton SJ, El-Heis S, Kenealy T, Nield H, Baker PN, Chong YS, Cutfield W, Chan SY; NiPPeR Study Group. Myo-Inositol, Probiotics, and Micronutrient Supplementation From Preconception for Glycemia in Pregnancy: NiPPeR International Multicenter Double-Blind Randomized Controlled Trial. Diabetes Care. 2021 May;44(5):1091-1099. doi: 10.2337/dc20-2515. Epub 2021 Mar 29.
Results Reference
derived
Links:
URL
http://www.nipperstudy.com
Description
Study Website

Learn more about this trial

Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health

We'll reach out to this number within 24 hrs